LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
228 hedge funds and large institutions have $5.13B invested in Loxo Oncology, Inc in 2018 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 93 increasing their positions, 68 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+15
Holders Change %
+7.04%
% of All Funds
5.22%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
41
Increased
93
Reduced
68
Closed
24
Calls
$36.8M
Puts
$21.6M
Net Calls
+$15.2M
Net Calls Change
-$2.31M
Top Buyers
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$49.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.1M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$43.8M |
| 4 |
Alkeon Capital Management
New York
|
+$34.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.6M |
Top Sellers
| 1 |
AC
Aisling Capital
New York
|
-$239M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$66.7M |
| 3 |
O
OrbiMed
New York
|
-$35.5M |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$27.9M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$26.1M |
